secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corteva, Inc. (CTVA)
CIK:        0001755672
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001755672-26-000002
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corteva FY2025 sales $17.4B (+3%), EBITDA $3.85B; guides 2026 EBITDA $4.0-4.2B; settles Bayer
--------------------------------------------------------------------------------

- Full-year GAAP EPS from cont ops $1.75, up 43% YoY; Operating EPS $3.34, up 30%.
- Seed net sales $9.9B (+4%), driven by price/mix +3% and volume +2%; operating EBITDA $2.64B (+19%).
- Crop Protection net sales $7.5B (+2%), volume +5% offset by price -2%; operating EBITDA $1.35B (+6%).
- Resolved all Bayer litigation; $610M cash outflow in Q1 2026; accelerates path to royalty neutrality by 2 years; expects $1B earnings upside over decade.
- Full-year 2026 guidance: Operating EBITDA $4.0-4.2B, Operating EPS $3.45-$3.70, implying ~7% growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755672/000175567226000002/0001755672-26-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755672/000175567226000002/ctva-20260203.htm
  HTML page:      https://secwatch.observer/filing/0001755672-26-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer